Myriad Genetics Inc
NASDAQ:MYGN
Myriad Genetics Inc
NASDAQ:MYGN
Price:
3.97
USD
-5.92%
Market Closed
Market Cap:
$371.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Myriad Genetics Inc
NASDAQ:MYGN
|
US |
|
Werner Enterprises Inc
NASDAQ:WERN
|
US |
|
G
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
US |
|
Carnival Corp
NYSE:CCL
|
US |
|
Metropolitan Bank Holding Corp
NYSE:MCB
|
US |
|
Novavax Inc
NASDAQ:NVAX
|
US |
|
Corsair Gaming Inc
NASDAQ:CRSR
|
US |
|
ONEOK Inc
NYSE:OKE
|
US |
Wall St Price Targets
MYGN Price Targets Summary
Myriad Genetics Inc
Myriad Genetics Inc
Wall Street analysts forecast MYGN stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MYGN is 6.35 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
Lowest Forecast
Price Target
4.04
USD
2% Upside
Average Forecast
Price Target
6.35
USD
60% Upside
Highest Forecast
Price Target
10.5
USD
164% Upside
Myriad Genetics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYGN's stock price target?
Price Target
6.35
USD
6.35
USD
According to Wall Street analysts, the average 1-year price target for MYGN is 6.35 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
